Is Klotho Neurosciences, Inc. (KLTO) a Buy, Sell, or Hold?
NASDAQ : KLTO
Klotho Neurosciences, Inc.
$0.381 USD
-$0.03 (-7.1%)
- Volume
- 95K
- Average Volume
- 3.23M
- Market Capitalization
- $20.08M
- P/E Ratio
- -1.13
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.91
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.74
Company Overview
NASDAQ
Joseph A. Sinkule
Biotechnology
Healthcare
KLTO
3
US
USD
Liquidity Metrics
0.01
19.74
19.74
18.06
0.00
Sales & Valuation
-$
0.00
0.69
-2.09
-0.10
Profitability
-$0.22
-$10.55M
0.00%
0.00%
-108.82%
-37.12%
P/E Metrics
-1.13
0.08
0.08
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
0.00
2/9
$10.38M
$59.74M
$8.27M
-$15.38M
Key Metrics (TTM)
$10.37M
0.00
-0.67
19.74
-108.82%
-25.34%
-62.10%
-47.81%
0 days
Company Executives
| Name | Title |
|---|---|
| Joseph Sinkule | Founder, Chief Executive Officer, Chairman of the Board & Secretary |
| Shalom Z. Hirschman | Medical Advisor & Director |
| Jeffrey LeBlanc | Chief Financial Officer |
| Peter J. Moriarty | Chief Business Officer |
| Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant |
Poll Results
No votes yet today — be the first to share your view!
About Klotho Neurosciences, Inc. (NASDAQ:KLTO) Stock
Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders. Their leading gene therapy assets encompass AMI-101, which is designed for the management or prevention of Alzheimer's disease, and AMI-202, aimed at treating or averting amyotrophic lateral sclerosis. Formerly known as Anew Medical, Inc., the company underwent a name change to Klotho Neurosciences, Inc. in September 2024. The firm's main office is situated in Omaha, Nebraska. ...
Frequently Asked Questions
-
What is the current Klotho Neurosciences, Inc. (KLTO) stock price?
-
Klotho Neurosciences, Inc.(NASDAQ:KLTO) stock price is $0.381 in the last trading session. During the trading session, KLTO stock reached the peak price of $3.91 while $0.114 was the lowest point it dropped to. The percentage change in KLTO stock occurred in the recent session was --7.1% while the dollar amount for the price change in KLTO stock was -$0.03.
-
KLTO's industry and sector of operation?
-
The NASDAQ listed KLTO is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of KLTO?
-
Joseph Sinkule | Founder, Chief Executive Officer, Chairman of the Board & Secretary
Shalom Z. Hirschman | Medical Advisor & Director
Jeffrey LeBlanc | Chief Financial Officer
Peter J. Moriarty | Chief Business Officer
Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant -
How many employees does KLTO have?
-
Number of KLTO employees currently stands at 3. KLTO operates from 13576 Walnut Street, Omaha, NE 68144, US.
-
Link for KLTO official website?
-
Official Website of KLTO is: https://greenlandmines.com
-
How do I contact KLTO?
-
KLTO could be contacted at phone #833 931 6330 and can also be accessed through its website. KLTO operates from 13576 Walnut Street, Omaha, NE 68144, US.
-
How many shares of KLTO are traded daily?
-
The average number of KLTO shares traded daily for last 3 months was 3.23M.
-
What is the market cap of KLTO currently?
-
The market value of KLTO currently stands at $20.08M with its latest stock price at $0.381